THE POLYMORPHIC OXIDATION OF BETA-ADRENOCEPTOR ANTAGONISTS

被引:24
作者
LENNARD, MS
机构
关键词
D O I
10.1016/0163-7258(89)90126-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:461 / 477
页数:17
相关论文
共 87 条
[1]  
ADAMS M, 1989, IN PRESS BR J PHARM
[2]  
AL-ASADY S A H, 1985, British Journal of Pharmacology, V85, p306P
[3]  
ALVAN G, 1982, LANCET, V1, P333
[4]  
BAI TR, 1982, J ROY COLL PHYS LOND, V16, P239
[5]  
BALANT L, 1976, SCHWEIZ MED WSCHR, V106, P1403
[6]  
BEELEY L, 1983, PRACTITIONER, V227, P1527
[7]   GENETIC-POLYMORPHISM IN DRUG OXIDATION - INVITRO STUDIES OF HUMAN DEBRISOQUINE 4-HYDROXYLASE AND BUFURALOL 1'-HYDROXYLASE ACTIVITIES [J].
BOOBIS, AR ;
MURRAY, S ;
HAMPDEN, CE ;
DAVIES, DS .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :65-71
[8]  
BORG KO, 1975, ACTA PHARMACOL TOX, V36, P125
[9]   ADVERSE-EFFECTS FROM METOPROLOL ARE NOT GENERALLY ASSOCIATED WITH OXIDATION STATUS [J].
CLARK, DWJ ;
MORGAN, AKW ;
WAALMANNING, H .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (06) :965-967
[10]  
CLEAVELAND CR, 1972, CLIN PHARMACOL THER, V13, P181